Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
Clinical trial NCT01813474 · COMPLETED
Trial details
- NCT number
- NCT01813474
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-25
- Primary completion
- 2016-08-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.